Μετάβαση στο περιεχόμενο
Global sound
PHASE3

PHASE3

NUKED: Access is everything, with GlyTherix and Telix Pharmaceuticals

· 30 λεπ.

Σημειώσεις επεισοδίου

In early 2023, one of the first two really big radiopharmaceutical drugs ran into a problem. Novartis' prostate cancer therapy Pluvicto, released only the year before, was suddenly in short supply, snarling up just in time treatment schedules.
In 2024 the supply chain problem is with the isotope Actinium 225, which *everyone* wants for clinical trials. RayzeBio has been a very famous victim, delaying a clinical trial because of the shortages.
In episode 2 of NUKED we explore where the nukes come from, and how biotechs large and small get their hands on them.
With GlyTherix CEO Dr Brad Walsh…

Ιστότοπος: podcasters.spotify.com

Ζωντανά, τελευταία ώρα: 15.549 τραγούδια σε 6.184 σταθμούς σε 146 χώρες

Ανακαλύψτε τον κόσμο μέσα από το ραδιόφωνο

Περισσότεροι τρόποι ανακάλυψης (9)

Ακούσατε κάτι ωραίο; Αποθηκεύστε το ή ανοίξτε το απευθείας στο Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio Caprice - Dub Techno [2]Συνέχεια ακρόασης